Relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: Phase II subgroup analysis mirroring the patient population of an upcoming phase III study Meeting Abstract


Authors: Colombo, N.; Van Gorp, T.; Matulonis, U. A.; Oaknin, A.; Grisham, R. N.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H. I.; Lorusso, D.
Abstract Title: Relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: Phase II subgroup analysis mirroring the patient population of an upcoming phase III study
Meeting Title: ESMO Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 7
Meeting Dates: 2022 Sep 9-13
Meeting Location: Paris, France
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: S793
Language: English
ACCESSION: WOS:000866211600529
DOI: 10.1016/j.annonc.2022.07.664
PROVIDER: wos
Notes: Meeting Abstract: 536P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rachel Nicole Grisham
    169 Grisham